- Country: USA
- Summary: Natera Signatera ctDNA Analysis for RIVAL Research Study
- UST Ref No: 113712110
- Deadline: 31 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 36C24E25Q0026
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
Regional Procurement Office (RPO) - East intends to negotiate on a sole source basis with Natera, Inc., to perform their perform circulating tumor DNA (ctDNA) analysis on approximately 40 patients with locally advanced non-small cell lung cancer (NSCLC) for a VA-funded research study by the VA Ann Arbor Healthcare System. STATEMENT OF WORKA. GENERAL INFORMATIONRequirement:The supplies and services requested by this contract are to support the following VA-funded research study: RIVAL: Repositioning Immunotherapy in VeterAns with Lung Cancer. One of the study objectives is to evaluate whether circulating tumor DNA (ctDNA), which is present in Veterans with locally advanced non-small cell lung cancer (NSCLC) will decrease following administration of chemotherapy plus immunotherapy (chemoIO) and whether the clearance of ctDNA can be used to predict progression-free survival. Signatera is a highly sensitive and personalized assay used to measure ctDNA that is owned by Natera. Participants in this study have a baseline sample that is sent to Natera through a separate contract between the National Precision Oncology Program (NPOP) and Natera. The RIVAL study proposes to collect samples for two additional time points: 9 weeks and 20 weeks post chemoimmunotherapy treatment. These samples would also be sent to Natera for ctDNA analysis.Natera will perform analysis on approximately 40 samples (20 patients x 2 time points. Sites participating in RIVAL a. VA Ann Arbor Healthcare System(Lead site responsible for payment of samples collected at each site) 2215 Fuller Rd. Ann Arbor MI, 48105 PI: Dr. Nithya Ramnath Louis Stokes Cleveland VA Medical Center 10701 E Blvd. Cleveland OH, 44106PI: Dr. Charles NockDurham VA Medical Center507 Fulton St. Durham NC, 27705 PI: Dr. Michael KelleyMichael E. DeBakey VA Medical Center2002 Holcombe Blvd. Houston TX, 77030 PI: Dr. Daniel ShinOmaha VA Medical Center4101 Woolworth Ave. Omaha NE, 68105 PI: Dr. Apar GantiRichmond VA Med... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNatera Signatera ctDNA Analysis for RIVAL Research Study - USA Tender
The VETERANS AFFAIRS, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Natera Signatera ctDNA Analysis for RIVAL Research Study. This tender is published on USARFP under UST Ref No: 113712110 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-31.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
